Aristeia Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-490,750
Closed -$5.32M – 890
2026
Q1
$5.32M Hold
490,750
– – 0.11% 139
2025
Q4
$5.25M Hold
490,750
– – 0.11% 116
2025
Q3
$5.2M Hold
490,750
– – 0.12% 108
2025
Q2
$5.18M Sell
490,750
-9,250
-2% -$96.7K 0.14% 106
2025
Q1
$5.15M Hold
500,000
– – 0.13% 98
2024
Q4
$5.07M Hold
500,000
– – 0.17% 90
2024
Q3
$5.04M Buy
+500,000
New +$5.01M 0.1% 64

Other funds holding GPAT

Aristeia Capital's GPAT Position: Q2 2026 in Review

Aristeia Capital sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 490,750 shares — an estimated $5.32M sold.

Aristeia Capital first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $5.32M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Aristeia Capital reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Aristeia Capital sold 490,750 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $5.32M.
  • Aristeia Capital first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
  • Aristeia Capital's GP-Act III Acquisition Corp position peaked at $5.32M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.